New York A 542: Initiates a four-year moratorium on privatization voting by Mitchell-Lama building shareholders

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A00542 Summary:

BILL NOA00542 

&nbsp

SAME ASSAME AS S03934

&nbsp

SPONSORPheffer Amato

&nbsp

COSPNSRGriffin

&nbsp

MLTSPNSR

&nbsp

Amd §§3302 & 3306, Pub Health L; amd §220.00, Pen L

&nbsp

Provides that a fentanyl analogue shall be deemed to be a schedule I opiate.

Go to top A00542 Actions:

BILL NOA00542 

&nbsp

01/08/2025referred to health

01/07/2026referred to health

Go to topA00542 Committee&nbspVotes:

Go to topA00542 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA00542 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 542

 2025-2026 Regular Sessions

 IN ASSEMBLY

 (Prefiled)

 January 8, 2025
 ___________

 Introduced by M. of A. PHEFFER AMATO -- read once and referred to the
 Committee on Health

 AN ACT to amend the public health law and the penal law, in relation to
 fentanyl analogues

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 3302 of the public health law is amended by adding
 2 a new subdivision 42 to read as follows:
 3 42. "Fentanyl analogue" (a) means any substance that is structurally
 4 related to fentanyl by one or more of the following modifications:
 5 (i) replacement of the phenyl portion of the phenethyl group by any
 6 monocycle, whether or not further substituted in or on the monocycle;
 7 (ii) substitution in or on the phenethyl group with alkyl, alkenyl,
 8 alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;
 9 (iii) substitution in or on the piperidine ring with alkyl, alkenyl,
 10 alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;
 11 (iv) replacement of the aniline ring with any aromatic monocycle
 12 whether or not further substituted in or on the aromatic monocycle;
 13 and/or
 14 (v) replacement of the N-propionyl group by another acyl group.
 15 (b) such term shall not include:
 16 (i) fentanyl;
 17 (ii) any substance for which there is an approved new drug application
 18 by the Federal Food and Drug Administration (FDA); or
 19 (iii) with respect to a particular person, any substance, if an
 20 exemption is in effect for investigational use for that person, as
 21 provided by 21 U.S.C. § 355, to the extent conduct with respect to the
 22 substance is pursuant to such exemption.
 23 § 2. Subdivision (b) of schedule I of section 3306 of the public
 24 health law is amended by adding a new paragraph 93 to read as follows:

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD02434-01-5

 A. 542 2

 1 (93) Any fentanyl analogue.
 2 § 3. Section 220.00 of the penal law is amended by adding a new subdi-
 3 vision 21 to read as follows:
 4 21. "Knowingly" when used in connection with an offense involving the
 5 possession or sale, or the attempt or conspiracy to possess or sell a
 6 fentanyl analogue, shall not require knowledge by a person of the chemi-
 7 cal structure of the substance.
 8 § 4. This act shall take effect immediately.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps